for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Business

U.S. Morning Call: A hostile drug deal may end well

Posted

July 16 - GlaxoSmithKline is expected to announce a deal to buy Human Genome Sciences after a 3-month long hostile takeover battle.

Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up